Our mission at Glaukos is to truly transform vision by pioneering novel platforms that can meaningfully advance the standard of care and improve outcomes for patients suffering from sight-threatening chronic eye diseases. Our mantra “We’ll Go First” embodies our commitment and determination to take chances and push the limits of science and technology to disrupt and improve the legacy treatment pa
radigms in glaucoma, corneal disorders and retinal diseases.
Please note when clicking links in our content you will be led outside of the Glaukos page. The site you opt to connect to does not adhere to our privacy policy. You are solely responsible for your interactions on outside websites.
Important Safety Information
https://www.glaukos.com/important-safety-information/
COMMUNITY GUIDELINES:
Glaukos welcomes interactions and will respond to questions, comments and feedback, but responses may be delayed or limited.
Posts and comments contain the opinions and views of other users and Glaukos is not responsible for their accuracy or reliability.
Do not post about financial, legal and regulatory issues, unsubstantiated claims about products, profanity, defamatory, offensive, discriminatory or demeaning content, threats, violence, illegal behavior, health or medical advice, false or misleading information, personal health information, or proprietary, confidential or sensitive information.
Follow Facebook's posting guidelines and terms of use.
By participating, you promise to comply with these guidelines, but we reserve the right to remove any posts that do not comply. Continuous violations may result in removal from the follower list and inability to receive news, comment or message/contact us.
Disclaimers:
Accounts followed by or following Glaukos social media channels do not indicate endorsement of the account, their products and services or content they publish.
Glaukos may provide links or references to other sites as part of its content, but it does not take responsibility for the content from those sites and shall not be liable for damages or injuries arising from it. These links are provided as a convenience only.
Glaukos reserves all rights to the channels, including the right to add, remove or modify content, discontinue the account, accept/reject followers and respond to comments.
Only Glaukos and its authorized users may represent Glaukos. Any other representation of Glaukos without authorization will result in legal action.
Medical Side Effects/Adverse Events:
If you believe you have experienced any medical side effects or reactions from the Glaukos iLink cross-linking procedure or iStent portfolio of products, consult your physician or healthcare professional and report it to Glaukos by calling 1-844-528-3376, Option 1 or by contacting the FDA at 1-800-FDA-1088.
Avoid sharing personal health information on social media channels, but if you do share information about any side effects, Glaukos may contact you for more information. Posts about side effects may be removed from our channels due to legal requirements.
Glaukos will not store or use your personal information, but if you report any adverse events or product issues, we need to store and use identifying information about you to submit it to Glaukos and/or regulatory authorities.
Please be aware that Facebook also has access to information shared on our channels, refer to Facebook's Privacy Policy for more details.
